SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: George Dysert who wrote (1562)11/3/1998 4:57:00 PM
From: Rudy Saucillo  Read Replies (4) of 2742
 
Wow, George. You were really fast on the trigger! :-)

Good deal in line with the Letter of Intent. No surprises.

Although it's not stated explicitly, PMC bought CIST shares at 75 cents/share.

Also, it's clear that PMC will study IL-1b as an adjuvant in a number of different vaccines, not just flu. They will also conduct their own research using IL-1b separately from CIST's inhouse research.

It will be interesting to see what else Naismith can pull from his pocket!

Rudy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext